Cargando…

M2 Macrophage-Derived Exosomal lncRNA MIR4435-2HG Promotes Progression of Infantile Hemangiomas by Targeting HNRNPA1

PURPOSE: Infantile hemangiomas (IHs) are commonly observed benign tumors that can cause serious complications. M2-polarized macrophages in IHs promote disease progression. In this study, we investigated the role of M2 macrophage-derived exosomal lncRNA MIR4435-2HG in IHs. PATIENTS AND METHODS: Exoso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhiyu, Cao, Zhongying, Li, Nanxi, Wang, Luying, Fu, Cong, Huo, Ran, Xu, Guangqi, Tian, Chonglin, Bi, Jianhai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596068/ https://www.ncbi.nlm.nih.gov/pubmed/37881607 http://dx.doi.org/10.2147/IJN.S435132

Ejemplares similares

LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer
por: Ouyang, Wen, et al.
Publicado: (2019)

LncRNA MIR4435-2HG is downregulated in osteoarthritis and regulates chondrocyte cell proliferation and apoptosis
por: Xiao, Yu, et al.
Publicado: (2019)

Expression and association of VEGF-Notch pathways in infantile hemangiomas
por: Li, Shangbin, et al.
Publicado: (2017)

Expression and association of VEGF-Notch pathways in infantile hemangiomas
por: Li, Shangbin, et al.
Publicado: (2018)

Biological Roles and Pathogenic Mechanisms of LncRNA MIR4435-2HG in Cancer: A Comprehensive Review
por: Chen, Zhou, et al.
Publicado: (2023)

MIR4435-2HG in exosomes promotes gastric carcinogenesis by inducing M2 polarization in macrophages
por: Li, Chaofeng, et al.
Publicado: (2022)

KIAA1429 promotes infantile hemangioma regression by facilitating the stemness of hemangioma endothelial cells
por: Wang, Luying, et al.
Publicado: (2023)

Circular RNA profile of infantile hemangioma by microarray analysis
por: Fu, Cong, et al.
Publicado: (2017)

LncRNA MIR4435-2HG inhibits the progression of osteoarthritis through miR-510-3p sponging
por: Liu, Yingli, et al.
Publicado: (2020)

lncRNA MIR4435-2HG promotes the progression of liver cancer by upregulating B3GNT5 expression
por: Zhu, Yungang, et al.
Publicado: (2022)

LncRNA MIR4435-2HG mediates cisplatin resistance in HCT116 cells by regulating Nrf2 and HO-1
por: Luo, Ping, et al.
Publicado: (2020)

lncRNA MIR4435-2HG promotes cancer cell migration and invasion in prostate carcinoma by upregulating TGF-β1
por: Zhang, Hui, et al.
Publicado: (2019)

lncRNA MIR4435-2HG Accelerates the Development of Bladder Cancer through Enhancing IQGAP3 and CDCA5 Expression
por: Yang, Tao, et al.
Publicado: (2022)

The lncRNA MIR4435-2HG is upregulated in hepatocellular carcinoma and promotes cancer cell proliferation by upregulating miRNA-487a
por: Kong, Qinglei, et al.
Publicado: (2019)

LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling
por: Wang, Haiyong, et al.
Publicado: (2019)

MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis
por: Zhong, Chenming, et al.
Publicado: (2022)

LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-128-3p/CKD14 axis
por: Zhu, Lijuan, et al.
Publicado: (2020)

Curative effect and safety of propranolol combined with prednisone in the treatment of infantile hemangiomas
por: Lou, Huanmin, et al.
Publicado: (2018)

LncRNA MIR4435‐2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR‐1224‐5p/TGFBR2 axis
por: Xu, Hongchao, et al.
Publicado: (2020)

Circular RNA expression profiles in the plasma of patients with infantile hemangioma determined using microarray analysis
por: Li, Zhiyu, et al.
Publicado: (2021)

LncRNA miR205HG hinders HNRNPA0 translation: anti‐oncogenic effects in esophageal carcinoma
por: Dong, Xiaoying, et al.
Publicado: (2021)

N6-methyladenosine-modified oncofetal lncRNA MIR4435-2HG contributed to stemness features of hepatocellular carcinoma cells by regulating rRNA 2′-O methylation
por: Zhu, Yiqing, et al.
Publicado: (2023)

LncRNA MIR4435‐2HG functions as a ceRNA against miR‐125a‐5p and promotes neuroglioma development by upregulating TAZ
por: Shen, Wangzhen, et al.
Publicado: (2021)

LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder
por: Pei, Lu, et al.
Publicado: (2023)

Identification of Long Non-Coding RNA MIR4435-2HG as a Prognostic Biomarker in Bladder Cancer
por: Hu, Zhiquan, et al.
Publicado: (2022)

Long Noncoding RNA MIR4435-2HG Suppresses Colorectal Cancer Initiation and Progression By Reprogramming Neutrophils
por: Yu, Hongfei, et al.
Publicado: (2022)

Fusobacterium nucleatum promotes epithelial‐mesenchymal transiton through regulation of the lncRNA MIR4435‐2HG/miR‐296‐5p/Akt2/SNAI1 signaling pathway
por: Zhang, Shuwei, et al.
Publicado: (2020)

mi-R4435-2HG promotes proliferation and inhibits apoptosis of cancer cells in ovarian carcinoma by upregulating ROCK2
por: Hu, Jinghui, et al.
Publicado: (2020)

lncRNA MIR4435‐2HG promoted clear cell renal cell carcinoma malignant progression via miR‐513a‐5p/KLF6 axis
por: Zhu, Kai, et al.
Publicado: (2020)

Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders
por: Ghasemian, Majid, et al.
Publicado: (2022)

Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m(6)A-dependent stabilization of TCF7L2 mRNA and colorectal cancer progression
por: Liu, Hao, et al.
Publicado: (2022)

Knockdown of lncRNA MIR4435-2HG and ST8SIA1 expression inhibits the proliferation, invasion and migration of prostate cancer cells in vitro and in vivo by blocking the activation of the FAK/AKT/β-catenin signaling pathway
por: Xing, Pengyi, et al.
Publicado: (2021)

Downregulation of long non-coding RNA MR4435-2HG suppresses breast cancer progression via the Wnt/β-catenin signaling pathway
por: Chen, Deqin, et al.
Publicado: (2021)

Long non-coding RNA MIR4435-2HG/microRNA-125a-5p axis is involved in myocardial ischemic injuries
por: Wang, Xiuling, et al.
Publicado: (2022)

Management of Infantile Hemangiomas
por: Reddy, Kavitha K
Publicado: (2014)

Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012)

Biology of Infantile Hemangioma
por: Itinteang, Tinte, et al.
Publicado: (2014)

Approach to Infantile Hemangiomas
por: Abraham, Anil, et al.
Publicado: (2016)

Infantile Periocular Hemangioma
por: Tavakoli, Mehdi, et al.
Publicado: (2017)

Update on infantile hemangioma
por: Jung, Hye Lim
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rmd7mk9rqso4rjqvm9phoqlmug